LSB - ysbiopharm.com Profit before deduction of interest, taxes, depreciation and amortization

Public company logo of ysbiopharm.com (LSB)

The EBITDA trend shown on this GURU.Markets chart is based on the implementation of closed robotic lines to ensure product sterility. Growth is supported by the development of unique adjuvants and the creation of new vaccines. The current commercialization stage of rabies and COVID vaccines strengthens the base. The value of captures the current state of the absolute operating profit parameter for LakeShore Biopharma Co. (LSB).

LakeShore Biopharma Co. (LSB) Operating profit EBITDA: for the period 07/04/2022 - 11/10/2026

LakeShore Biopharma (LSB) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price YS Biopharma Co., Ltd.|LSB - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation LakeShore Biopharma|LSB - Enterprise Value
- book capitalization indicators:
Net Asset Value per Share LakeShore Biopharma|LSB - Book Capitalization|Market Cap to Net Assets Ratio ysbiopharm.com|LSB - Cumulative Company Assets
- business debt structure and liquidity details:
Aggregate Debt to Capital LakeShore Biopharma Co.|LSB - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient LakeShore Biopharma Co., Ltd.|LSB - Company Debts|Debts to Book Value LakeShore Biopharma|LSB - Company Long-Term Debt|Company Short-Term Indebtedness LakeShore Biopharma|Interim Coverage Ratio ysbiopharm.com
- earnings and market multiples details:
LSB - Company Net Income|Expected Profit LakeShore Biopharma Co.|LSB - P/E Multiple|Forward P/E Multiple ysbiopharm.com|LSB - Price/Earnings to Growth Ratio|EV/EBITDA Multiple LakeShore Biopharma|LSB - Operating profit EBITDA|Net earnings per one share for the last twelve months LakeShore Biopharma|LSB - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months ysbiopharm.com|LSB - Earnings growth in current year|Expected earnings per share trend next year LakeShore Biopharma Co.
Analysis of all company metrics:LakeShore Biopharma Co.
Product sample of YS Biopharma

Absolute operating profit reflects the actual cash flow from core operations before depreciation and taxes, allowing for an assessment of business efficiency without accounting adjustments. By analyzing the consolidated EBITDA, an investor can identify hidden financial pressure on LakeShore Biopharma (LSB), driven by high vaccine development costs and regulatory risks within the Chinese market.

Competitors of LakeShore Biopharma Co. (LSB)

SMMT: Operating profit before amortization|Moderna, Inc. - Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization PCVX|TARS: Operating profit EBITDA|Profit before interest, taxes and amortization CorMedix Inc (CRMD)|MCRB (Seres) - Operating profit EBITDA|Operating profit before deduction of amortization Spero Pharma (SPRO)|Operating profit before deduction of amortization SCYX (SCYNEXIS, Inc.)|Company profit before taxes, interest and amortization ANTX|Operating profit EBITDA PYPD (PolyPid)|Operating income before deduction of amortization Iterum Therapeutics PLC (ITRM)|PHGE - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Soligenix, Inc.|60degreespharma.com (SXTP) - Profit before payment of interest, taxes and amortization|Operating profit before amortization OGEN|Profit before payment of interest, taxes and amortization OpGen